Member Exclusive News

The week in industry: FDA approves opioid alternative - DSUVIA

This week: US filling for biosimilar of rituximab terminated and BIA granted permission to intervene in Supreme Court case.

Go to the profile of RxNet
Nov 08, 2018

Please sign in or register for FREE

No comments yet.